92 related articles for article (PubMed ID: 20617520)
21. Pharmacological evaluation of LH-21, a newly discovered molecule that binds to cannabinoid CB1 receptor.
Chen RZ; Frassetto A; Lao JZ; Huang RR; Xiao JC; Clements MJ; Walsh TF; Hale JJ; Wang J; Tong X; Fong TM
Eur J Pharmacol; 2008 Apr; 584(2-3):338-42. PubMed ID: 18336811
[TBL] [Abstract][Full Text] [Related]
22. CB1 receptor deficiency decreases wheel-running activity: consequences on emotional behaviours and hippocampal neurogenesis.
Dubreucq S; Koehl M; Abrous DN; Marsicano G; Chaouloff F
Exp Neurol; 2010 Jul; 224(1):106-13. PubMed ID: 20138171
[TBL] [Abstract][Full Text] [Related]
23. The pharmacology of cannabinoid receptors and their ligands: an overview.
Pertwee RG
Int J Obes (Lond); 2006 Apr; 30 Suppl 1():S13-8. PubMed ID: 16570099
[TBL] [Abstract][Full Text] [Related]
24. [The endocannabinoid system as a novel target for the treatment of liver fibrosis].
Teixeira-Clerc F; Julien B; Grenard P; Tran Van Nhieu J; Deveaux V; Hezode C; Mallat A; Lotersztajn S
Pathol Biol (Paris); 2008 Feb; 56(1):36-8. PubMed ID: 17412522
[TBL] [Abstract][Full Text] [Related]
25. Cannabinoid receptors in microglia of the central nervous system: immune functional relevance.
Cabral GA; Marciano-Cabral F
J Leukoc Biol; 2005 Dec; 78(6):1192-7. PubMed ID: 16204639
[TBL] [Abstract][Full Text] [Related]
26. Activation of human T cells induces upregulation of cannabinoid receptor type 1 transcription.
Börner C; Höllt V; Kraus J
Neuroimmunomodulation; 2007; 14(6):281-6. PubMed ID: 18287809
[TBL] [Abstract][Full Text] [Related]
27. Specific detection of CB1 receptors; cannabinoid CB1 receptor antibodies are not all created equal!
Grimsey NL; Goodfellow CE; Scotter EL; Dowie MJ; Glass M; Graham ES
J Neurosci Methods; 2008 Jun; 171(1):78-86. PubMed ID: 18406468
[TBL] [Abstract][Full Text] [Related]
28. Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis.
Wilkinson JD; Williamson EM
J Dermatol Sci; 2007 Feb; 45(2):87-92. PubMed ID: 17157480
[TBL] [Abstract][Full Text] [Related]
29. The effects of charge-neutralizing mutation D6.30N on the functions of CB1 and CB2 cannabinoid receptors.
Nebane NM; Kellie B; Song ZH
FEBS Lett; 2006 Oct; 580(22):5392-8. PubMed ID: 16989818
[TBL] [Abstract][Full Text] [Related]
30. Novel insights in the pathogenesis of systemic sclerosis.
Radstake TR
Expert Rev Clin Immunol; 2011 Jul; 7(4):389-90. PubMed ID: 21790277
[No Abstract] [Full Text] [Related]
31. Can Cannabinoids Modulate Fibrotic Progression in Systemic Sclerosis?
Garcia-Gonzalez E; Galeazzi M; Selvi E
Isr Med Assoc J; 2016; 18(3-4):156-8. PubMed ID: 27228633
[No Abstract] [Full Text] [Related]
32. The cannabinoid receptor 1 is involved in renal fibrosis during chronic allograft dysfunction: Proof of concept.
Dao M; Lecru L; Vandermeersch S; Ferreira M; Ferlicot S; Posseme K; Dürrbach A; Hermeziu B; Mussini C; Chatziantoniou C; François H
J Cell Mol Med; 2019 Nov; 23(11):7279-7288. PubMed ID: 31469511
[TBL] [Abstract][Full Text] [Related]
33. Functional Analysis of Mitochondrial CB1 Cannabinoid Receptors (mtCB1) in the Brain.
Melser S; Pagano Zottola AC; Serrat R; Puente N; Grandes P; Marsicano G; Hebert-Chatelain E
Methods Enzymol; 2017; 593():143-174. PubMed ID: 28750801
[TBL] [Abstract][Full Text] [Related]
34. Cannabinoid-related olfactory neuroscience in mice and humans.
Lötsch J; Hummel T
Chem Senses; 2015 Jan; 40(1):3-5. PubMed ID: 25392453
[No Abstract] [Full Text] [Related]
35. Antibodies to cannabinoid type 1 receptor co-react with stomatin-like protein 2 in mouse brain mitochondria.
Morozov YM; Dominguez MH; Varela L; Shanabrough M; Koch M; Horvath TL; Rakic P
Eur J Neurosci; 2013 Aug; 38(3):2341-8. PubMed ID: 23617247
[TBL] [Abstract][Full Text] [Related]
36. A unifying hypothesis for scleroderma: identifying a target cell for scleroderma.
Mahoney WM; Fleming JN; Schwartz SM
Curr Rheumatol Rep; 2011 Feb; 13(1):28-36. PubMed ID: 21181314
[TBL] [Abstract][Full Text] [Related]
37. Fit-for-purpose based testing and validation of antibodies to amino- and carboxy-terminal domains of cannabinoid receptor 1.
Echeazarra L; García Del Caño G; Barrondo S; González-Burguera I; Saumell-Esnaola M; Aretxabala X; López de Jesús M; Borrega-Román L; Mato S; Ledent C; Matute C; Goicolea MA; Sallés J
Histochem Cell Biol; 2021 Nov; 156(5):479-502. PubMed ID: 34453219
[TBL] [Abstract][Full Text] [Related]
38. The Cannabinoid Receptor 1 as a Key Mediator of Adolescent Behavior.
Spanagel R; Kiefer F
Neuropsychopharmacology; 2017 Jan; 42(1):367. PubMed ID: 27909319
[No Abstract] [Full Text] [Related]
39. Animal models of systemic sclerosis.
Jimenez SA; Christner P
Clin Dermatol; 1994; 12(3):425-36. PubMed ID: 7954200
[No Abstract] [Full Text] [Related]
40. [Systemic sclerosis].
Kashiwazaki S
Nihon Rinsho; 1978 May; Suppl():1230-1. PubMed ID: 691306
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
